I don't think it is as bad as you are making out, it the numbers keep around the same pace we should be profitable in 2019, I think around 9.6 million in earnings in 2019 with an EPS of around 0.037c, share price at 68c.
That is without any help from the blue sky opportunities in Vaccines, TAVR or TMVR.
There will probably be a continued downtrend until 2019 unless another large hospital contract occurs.
Admedus Trend line, page-2
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.70 |
Change
-0.300(1.58%) |
Mkt cap ! $359.4M | |||
| Open | High | Low | Value | Volume |
| $19.00 | $19.00 | $18.62 | $180.3K | 9.596K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 475 | $18.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.91 | 100 | 1 |
View Market Depth
| Last trade - 14.41pm 20/06/2024 (20 minute delay) ? |
| AVR (ASX) Chart |